Rigel Pharmaceuticals, Inc. (RIGL)

NASDAQ: RIGL · Real-Time Price · USD

28.87

-0.65 (-2.20%)

At close: Mar 6, 2026, 4:00 PM EST

28.60

-0.27 (-0.94%)

After-hours: Mar 6, 2026, 4:52 PM EST

Rigel Pharmaceuticals Market Cap

Rigel Pharmaceuticals has a market cap or net worth of $533.32 million as of March 6, 2026. Its market cap has increased by 45.36% in one year.

Market Cap

533.32M

Enterprise Value

431.67M

1-Year Change

45.36%

Ranking

#2976

Market Cap Chart

Since November 29, 2000, Rigel Pharmaceuticals's market cap has increased from $254.90M to $533.32M, an increase of 109.23%. That is a compound annual growth rate of 2.96%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	533.30M	-31.40%
Dec 31, 2025	777.40M	162.37%
Dec 31, 2024	296.30M	17.21%
Dec 29, 2023	252.80M	-2.51%
Dec 30, 2022	259.30M	-42.78%
Dec 31, 2021	453.20M	-23.37%
Dec 31, 2020	591.40M	64.87%
Dec 31, 2019	358.70M	-6.42%
Dec 31, 2018	383.30M	-32.57%
Dec 29, 2017	568.40M	141.36%
Dec 30, 2016	235.50M	-12.19%
Dec 31, 2015	268.20M	34.57%
Dec 31, 2014	199.30M	-20.02%
Dec 31, 2013	249.20M	-55.93%
Dec 31, 2012	565.50M	0.60%
Dec 30, 2011	562.10M	43.14%
Dec 31, 2010	392.70M	-20.31%
Dec 31, 2009	492.80M	68.36%
Dec 31, 2008	292.70M	-62.86%
Dec 31, 2007	788.20M	164.67%
Dec 29, 2006	297.80M	47.43%
Dec 30, 2005	202.00M	-57.71%
Dec 31, 2004	477.70M	68.26%
Dec 31, 2003	283.90M	465.54%
Dec 31, 2002	50.20M	-71.28%

View and export this data all the way back to 2000. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Alpha Tau Medical	546.54M
Fulcrum Therapeutics	544.12M
Ocugen	527.90M
Solid Biosciences	525.89M
Allogene Therapeutics	516.88M
Prothena Corporation	516.26M
Neumora Therapeutics	513.21M
Forte Biosciences	512.83M

Market Cap Rankings